Prunieras M |
Melanocytes, melanogenesis, and inflammation. |
1986 |
Int. J. Dermatol. |
pmid:2433237
|
Schleimer RP et al. |
Selective inhibition of arachidonic acid metabolite release from human lung tissue by antiinflammatory steroids. |
1986 |
J. Immunol. |
pmid:3082976
|
Etienne A et al. |
In vivo inhibition of plasma protein leakage and Salmonella enteritidis-induced mortality in the rat by a specific paf-acether antagonist: BN 52021. |
1986 |
Agents Actions |
pmid:3515870
|
Nunez D et al. |
Specific inhibition of PAF-acether-induced platelet activation by BN 52021 and comparison with the PAF-acether inhibitors kadsurenone and CV 3988. |
1986 |
Eur. J. Pharmacol. |
pmid:3086108
|
Oxholm P and Winther K |
Thrombocyte involvement in immune inflammatory reactions. |
1986 |
Allergy |
pmid:3515999
|
Wallace JL and Whittle BJ |
Picomole doses of platelet-activating factor predispose the gastric mucosa to damage by topical irritants. |
1986 |
Prostaglandins |
pmid:3726156
|
DeFeudis FV |
Possible relationship between the syntheses of endothelium-derived relaxing factor (EDRF) and PAF-acether. |
1986 |
Gen. Pharmacol. |
pmid:3516791
|
Eche N et al. |
Platelet aggregating and procoagulant activities of cultured human breast cancer cells (FAM). |
1986 |
Thromb. Res. |
pmid:3726808
|
Camussi G |
Potential role of platelet-activating factor in renal pathophysiology. |
1986 |
Kidney Int. |
pmid:3517457
|
Hoffman DR et al. |
The role of platelet-activating factor in human fetal lung maturation. |
1986 |
Am. J. Obstet. Gynecol. |
pmid:3728606
|
Conrad GW and Rink TJ |
Platelet activating factor raises intracellular calcium ion concentration in macrophages. |
1986 |
J. Cell Biol. |
pmid:3733874
|
Wardlaw AJ et al. |
Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. |
1986 |
J. Clin. Invest. |
pmid:3023451
|
Sybertz EJ et al. |
AGEPC, a vasodilator phospholipid with profound circulatory actions. |
1986 |
Prog. Clin. Biol. Res. |
pmid:3538024
|
Sugatani J and Hanahan DJ |
Characterization of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (AGEPC)-induced protein phosphorylation in rabbit platelets: inhibitory effects of AGEPC analogs. |
1986 |
Arch. Biochem. Biophys. |
pmid:3754710
|
McGowan HM et al. |
Increased aortic PGI2 and plasma lyso-PAF in the unclipped one-kidney hypertensive rat. |
1986 |
Am. J. Physiol. |
pmid:3538908
|
Hsueh W et al. |
Platelet activating factor-induced ischemic bowel necrosis: the effect of PAF antagonists. |
1986 |
Eur. J. Pharmacol. |
pmid:3754817
|
Hemmendinger S et al. |
[Methods of studying platelet function. Biological markers of the activation of human platelets in vivo and in vitro]. |
1986 |
Ann. Biol. Clin. (Paris) |
pmid:3538949
|
Okamoto M et al. |
Platelet activating factor (PAF) involvement in endotoxin-induced thrombocytopenia in rabbits: studies with FR-900452, a specific inhibitor of PAF. |
1986 |
Thromb. Res. |
pmid:3754990
|
Villamediana LM et al. |
Effects of the platelet-activating factor antagonist BN 52021 on the hemodynamics of rats with experimental cirrhosis of the liver. |
1986 |
Life Sci. |
pmid:3755490
|
Alloatti G et al. |
Effect of platelet-activating factor (PAF) on human cardiac muscle. |
1986 |
Int. Arch. Allergy Appl. Immunol. |
pmid:3941007
|
Wallace JL and Whittle BJ |
Prevention of endotoxin-induced gastrointestinal damage by CV-3988, an antagonist of platelet-activating factor. |
1986 |
Eur. J. Pharmacol. |
pmid:3720841
|
Oh-ishi S et al. |
Suppression of phorbol myristate acetate-induced pleurisy by CV-3988, an antagonist of platelet-activating factor. |
1986 |
Chem. Pharm. Bull. |
pmid:3829203
|
Flower RJ |
Background and discovery of lipocortins. |
1986 |
Agents Actions |
pmid:2938452
|
Ramesha CS and Pickett WC |
Measurement of sub-picogram quantities of platelet activating factor (AGEPC) by gas chromatography/negative ion chemical ionization mass spectrometry. |
1986 |
Biomed. Environ. Mass Spectrom. |
pmid:2938649
|
Resink TJ et al. |
The influence of activating hormones on human platelet membrane Ca2+-ATPase activity. |
1986 |
Biochem. Biophys. Res. Commun. |
pmid:2943273
|
Gay JC et al. |
Modulation of neutrophil oxidative responses to soluble stimuli by platelet-activating factor. |
1986 |
Blood |
pmid:3006836
|
Wade PJ et al. |
Effect of calcium and calcium antagonists on [3H]-Paf-acether binding to washed human platelets. |
1986 |
Thromb. Res. |
pmid:3961730
|
Schlondorff D et al. |
Different concentrations of pertussis toxin have opposite effects on agonist-induced PGE2 formation in mesangial cells. |
1986 |
Biochem. Biophys. Res. Commun. |
pmid:3099783
|
Cox CP |
Effects of CV-3988, an antagonist of platelet-activating factor (PAF), on washed rabbit platelets. |
1986 |
Thromb. Res. |
pmid:2421432
|
Schleimer RP et al. |
Characterization of inflammatory mediator release from purified human lung mast cells. |
1986 |
Am. Rev. Respir. Dis. |
pmid:3485946
|
Okamoto M et al. |
Studies of platelet activating factor (PAF) antagonists from microbial products. I. Bisdethiobis(methylthio)gliotoxin and its derivatives. |
1986 |
Chem. Pharm. Bull. |
pmid:2421923
|
Robertson DN and Smith GM |
CV3988 inhibits in vivo platelet aggregation induced by PAF-acether and collagen. |
1986 |
Eur. J. Pharmacol. |
pmid:3709663
|
Kohayakawa M and Inoue K |
Augmentation of 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (PAF)-induced human platelet activation by C-reactive protein. |
1986 |
Thromb. Res. |
pmid:3083530
|
Morley J et al. |
Effects of ketotifen upon responses to platelet activating factor: a basis for asthma prophylaxis. |
1986 |
Ann Allergy |
pmid:3083731
|
McIntosh TK and Faden AI |
Thyrotropin-releasing hormone (TRH) and circulatory shock. |
1986 |
Circ. Shock |
pmid:3084122
|
Swingle KF and Reiter MJ |
Inhibition of Paf-acether-induced edema of the rat's paw. |
1986 |
Agents Actions |
pmid:2875631
|
Ghezzi E |
Autacoids and some mediators in allergic and non allergic forms. |
1986 |
Boll Ist Sieroter Milan |
pmid:2877678
|
Raphael GD and Metcalfe DD |
Mediators of airway inflammation. |
1986 |
Eur J Respir Dis Suppl |
pmid:2429857
|
Yoshida J et al. |
A platelet-aggregating and hypotensive phospholipid isolated from bovine brain. |
1986 |
J. Pharm. Pharmacol. |
pmid:2880959
|
McIntyre TM et al. |
Leukotrienes C4 and D4 stimulate human endothelial cells to synthesize platelet-activating factor and bind neutrophils. |
1986 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:3457383
|
Di Marzo V et al. |
The effect of vasoactive intestinal peptide and calcitonin gene-related peptide on peptidoleukotriene release from platelet activating factor stimulated rat lungs and ionophore stimulated guinea pig lungs. |
1986 |
Biochem. Int. |
pmid:2432897
|
Oh S et al. |
Inflammatory effects of acetylglycerylether phosphorylcholine: vascular permeability increase and induction of pleurisy in rats. |
1986 |
Prostaglandins Leukot Med |
pmid:3459197
|
Newhouse MT and Sears MR |
Platelet activating factor, ketotifen and asthma. |
1986 |
N. Z. Med. J. |
pmid:3462569
|
Chignard M et al. |
Direct evidence for the existence of a neutrophil-derived platelet activator (neutrophilin). |
1986 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:3464972
|
Kloprogge E and Akkerman JW |
Platelet-activating factor (PAF-acether) induces high- and low-affinity binding of fibrinogen to human platelets via independent mechanisms. |
1986 |
Biochem. J. |
pmid:3101672
|
Vilain B et al. |
Pharmacological control of the in vivo passive anaphylactic shock by the PAF-acether antagonist compound BN 52021. |
1986 |
Pharmacol Res Commun |
pmid:3774840
|
Bessin P |
PAF-acether and leukotriene participation in acute circulatory shock. |
1986 |
Pharmacol Res Commun |
pmid:3774841
|
Goldstein RE et al. |
Coronary and pulmonary vascular effects of leukotrienes and PAF-acether. |
1986 |
Pharmacol Res Commun |
pmid:3774842
|
Plante GE et al. |
Hemodynamic effects of PAF-acether. |
1986 |
Pharmacol Res Commun |
pmid:3774843
|
Sanchez Crespo M et al. |
Evidence of a role for PAF-acether in the pathophysiology of the shock state. |
1986 |
Pharmacol Res Commun |
pmid:3774844
|